CFAP73
gene geneOn this page
Also known as MIA2
Summary
CFAP73 (cilia and flagella associated protein 73, HGNC:37100) is a protein-coding gene on chromosome 12q24.13, encoding Cilia- and flagella-associated protein 73 (A6NFT4). May play a role in ciliary/flagellar motility by regulating the assembly and the activity of axonemal inner dynein arm.
Predicted to enable dynein complex binding activity. Predicted to be involved in cilium movement and inner dynein arm assembly. Predicted to be located in axonemal doublet microtubule and motile cilium.
Source: NCBI Gene 387885 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 90 total — 2 pathogenic
- MANE Select transcript:
NM_001144872
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37100 |
| Approved symbol | CFAP73 |
| Name | cilia and flagella associated protein 73 |
| Location | 12q24.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MIA2 |
| Ensembl gene | ENSG00000186710 |
| Ensembl biotype | protein_coding |
| Entrez | 387885 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 8 protein_coding, 1 retained_intron
ENST00000335621, ENST00000550918, ENST00000551256, ENST00000865198, ENST00000865199, ENST00000865200, ENST00000865201, ENST00000865202, ENST00000949583
RefSeq mRNA: 1 — MANE Select: NM_001144872
NM_001144872
CCDS: CCDS44983
Canonical transcript exons
ENST00000335621 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001424124 | 113153208 | 113153408 |
| ENSE00001426498 | 113152783 | 113152887 |
| ENSE00001428878 | 113151918 | 113152023 |
| ENSE00001561969 | 113149724 | 113149913 |
| ENSE00002313940 | 113158701 | 113159276 |
| ENSE00003496707 | 113155260 | 113155418 |
| ENSE00003549083 | 113154414 | 113154635 |
| ENSE00003586153 | 113157602 | 113157690 |
Expression profiles
Bgee: expression breadth ubiquitous, 188 present calls, max score 99.33.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0390 / max 15.2469, expressed in 7 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 128145 | 0.0390 | 7 |
Top tissues by expression
231 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 99.33 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 93.23 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 90.21 | silver quality |
| parotid gland | UBERON:0001831 | 87.94 | silver quality |
| bronchial epithelial cell | CL:0002328 | 87.21 | gold quality |
| bronchus | UBERON:0002185 | 86.57 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 86.00 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 84.36 | silver quality |
| fallopian tube | UBERON:0003889 | 81.39 | gold quality |
| biceps brachii | UBERON:0001507 | 80.67 | silver quality |
| cerebellar vermis | UBERON:0004720 | 80.60 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 80.16 | gold quality |
| caput epididymis | UBERON:0004358 | 79.77 | gold quality |
| upper arm skin | UBERON:0004263 | 79.58 | gold quality |
| heart right ventricle | UBERON:0002080 | 79.50 | silver quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 79.06 | silver quality |
| kidney epithelium | UBERON:0004819 | 78.29 | gold quality |
| right lung | UBERON:0002167 | 78.19 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 77.45 | silver quality |
| tibialis anterior | UBERON:0001385 | 76.44 | silver quality |
| vena cava | UBERON:0004087 | 76.42 | silver quality |
| left uterine tube | UBERON:0001303 | 76.16 | gold quality |
| oocyte | CL:0000023 | 76.06 | gold quality |
| decidua | UBERON:0002450 | 76.04 | silver quality |
| entorhinal cortex | UBERON:0002728 | 75.68 | silver quality |
| cauda epididymis | UBERON:0004360 | 75.67 | silver quality |
| cartilage tissue | UBERON:0002418 | 75.51 | silver quality |
| postcentral gyrus | UBERON:0002581 | 75.48 | silver quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 75.47 | gold quality |
| corpus epididymis | UBERON:0004359 | 75.36 | silver quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 63.52 |
| E-HCAD-4 | yes | 53.26 |
| E-ANND-3 | yes | 11.17 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
22 targeting CFAP73, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-646 | 99.68 | 67.84 | 1645 |
| HSA-MIR-892A | 99.54 | 68.16 | 1141 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-4688 | 99.48 | 64.68 | 828 |
| HSA-MIR-6878-3P | 99.24 | 64.23 | 920 |
| HSA-MIR-4291 | 99.20 | 68.88 | 2969 |
| HSA-MIR-922 | 99.02 | 67.23 | 1838 |
| HSA-MIR-3619-5P | 99.00 | 68.87 | 2308 |
| HSA-MIR-3154 | 98.94 | 66.55 | 1455 |
| HSA-MIR-7113-3P | 98.75 | 65.71 | 1120 |
| HSA-MIR-214-3P | 98.71 | 68.12 | 2128 |
| HSA-MIR-761 | 98.71 | 68.07 | 2051 |
| HSA-MIR-31-5P | 98.58 | 68.35 | 1239 |
| HSA-MIR-1291 | 96.28 | 65.89 | 1224 |
| HSA-MIR-654-5P | 96.07 | 66.18 | 1280 |
| HSA-MIR-6775-3P | 95.76 | 65.91 | 982 |
| HSA-MIR-6850-5P | 94.72 | 64.25 | 62 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cfap73 | ENSDARG00000035550 |
| mus_musculus | Cfap73 | ENSMUSG00000094282 |
| rattus_norvegicus | Cfap73 | ENSRNOG00000056407 |
Paralogs (3): CCDC42 (ENSG00000161973), CFAP100 (ENSG00000163885), CCDC38 (ENSG00000165972)
Protein
Protein identifiers
Cilia- and flagella-associated protein 73 — A6NFT4 (reviewed: A6NFT4)
Alternative names: Coiled-coil domain-containing protein 42B
All UniProt accessions (2): A6NFT4, H0YHK5
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in ciliary/flagellar motility by regulating the assembly and the activity of axonemal inner dynein arm.
Subcellular location. Cytoplasm. Cytoskeleton. Cilium axoneme.
Similarity. Belongs to the CFAP73 family.
RefSeq proteins (1): NP_001138344* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025252 | DUF4200 | Domain |
| IPR051147 | CFAP_domain-containing | Family |
Pfam: PF13863
UniProt features (3 total): coiled-coil region 2, chain 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8J07 | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NFT4-F1 | 88.57 | 0.70 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 300 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP, TAATAAT_MIR126, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, CHUANG_OXIDATIVE_STRESS_RESPONSE_UP, MORF_ATRX, GOBP_VESICLE_MEDIATED_TRANSPORT, HNF1_Q6, REACTOME_MEMBRANE_TRAFFICKING, GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM, GOBP_INNER_DYNEIN_ARM_ASSEMBLY, GOBP_AXONEMAL_DYNEIN_COMPLEX_ASSEMBLY, GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT, MYCMAX_01, DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN, GOBP_CILIUM_ORGANIZATION
GO Biological Process (2): cilium movement (GO:0003341), inner dynein arm assembly (GO:0036159)
GO Molecular Function (1): dynein complex binding (GO:0070840)
GO Cellular Component (6): motile cilium (GO:0031514), axonemal doublet microtubule (GO:0097545), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cilium (GO:0005929), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| microtubule-based movement | 1 |
| axonemal dynein complex assembly | 1 |
| protein-containing complex binding | 1 |
| cilium | 1 |
| axoneme | 1 |
| A axonemal microtubule | 1 |
| B axonemal microtubule | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Protein interactions and networks
STRING
332 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFAP73 | CCDC38 | Q502W7 | 632 |
| CFAP73 | CFAP100 | Q494V2 | 603 |
| CFAP73 | RITA1 | Q96K30 | 533 |
| CFAP73 | RIMBP3B | A6NNM3 | 487 |
| CFAP73 | DRC10 | Q96DY2 | 484 |
| CFAP73 | CCDC40 | Q4G0X9 | 475 |
| CFAP73 | CCDC39 | Q9UFE4 | 466 |
| CFAP73 | TDRD15 | B5MCY1 | 463 |
| CFAP73 | CFAP157 | Q5JU67 | 419 |
| CFAP73 | FAM174C | Q9BVV8 | 419 |
| CFAP73 | BRD10 | Q5HYC2 | 418 |
| CFAP73 | PRSS37 | A4D1T9 | 414 |
| CFAP73 | RIMBP3C | A6NJZ7 | 412 |
| CFAP73 | PPP1R42 | Q7Z4L9 | 410 |
| CFAP73 | DRC5 | Q5JU00 | 404 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NFKB1 | NFKB1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (2): CCDC42B (Affinity Capture-MS), CCDC42B (Affinity Capture-RNA)
ESM2 similar proteins: A4FV37, A4IFI1, A5D8V7, A6NC98, A6NFT4, A6NGB0, A6QQM8, A9UQN0, B0BMJ2, B0BNK9, D3Z5T1, D6REC4, J3QPZ5, O00411, O60826, O94812, P0C7Q1, P0CW27, P86182, Q0P5D1, Q13515, Q15834, Q17Q97, Q1RMI8, Q2M329, Q3V3V9, Q494R4, Q4QRL3, Q571B6, Q58EX7, Q5BK61, Q5FVL4, Q5ND29, Q5SPX1, Q66H85, Q6F5E8, Q6NTM6, Q6PDY0, Q7TMK6, Q80ZJ8
Diamond homologs: A6NFT4, A6QQM8, A7S8T5, A9UQN0, B0BMJ2, J3QPZ5, Q5SV66, Q6NTM6, Q96M95, Q3KPZ2, M1V4Y8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
90 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 73 |
| Likely benign | 6 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1527733 | GRCh37/hg19 12q24.13-24.21(chr12:113445811-114933860) | Pathogenic |
| 155465 | GRCh38/hg38 12q24.13-24.21(chr12:113077775-114372366)x1 | Pathogenic |
SpliceAI
1435 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:113149914:G:GG | donor_gain | 1.0000 |
| 12:113151902:ACTT:A | acceptor_gain | 1.0000 |
| 12:113152778:CCCA:C | acceptor_loss | 1.0000 |
| 12:113152779:CCAG:C | acceptor_loss | 1.0000 |
| 12:113152781:A:AG | acceptor_gain | 1.0000 |
| 12:113152781:AGG:A | acceptor_loss | 1.0000 |
| 12:113152782:G:GG | acceptor_gain | 1.0000 |
| 12:113152782:GGT:G | acceptor_gain | 1.0000 |
| 12:113152884:GCAG:G | donor_gain | 1.0000 |
| 12:113152886:AG:A | donor_gain | 1.0000 |
| 12:113152887:GG:G | donor_gain | 1.0000 |
| 12:113152888:G:GG | donor_gain | 1.0000 |
| 12:113153196:C:CA | acceptor_gain | 1.0000 |
| 12:113153199:A:AG | acceptor_gain | 1.0000 |
| 12:113154412:A:AG | acceptor_gain | 1.0000 |
| 12:113154413:G:GG | acceptor_gain | 1.0000 |
| 12:113154617:G:GT | donor_gain | 1.0000 |
| 12:113154632:G:GG | donor_gain | 1.0000 |
| 12:113155415:GCAC:G | donor_gain | 1.0000 |
| 12:113155419:G:GG | donor_gain | 1.0000 |
| 12:113149910:CTACG:C | donor_loss | 0.9900 |
| 12:113149911:TACGT:T | donor_loss | 0.9900 |
| 12:113149912:ACGT:A | donor_loss | 0.9900 |
| 12:113149913:CGTG:C | donor_loss | 0.9900 |
| 12:113149914:GTG:G | donor_loss | 0.9900 |
| 12:113149915:T:G | donor_loss | 0.9900 |
| 12:113149922:G:GT | donor_gain | 0.9900 |
| 12:113149922:G:T | donor_gain | 0.9900 |
| 12:113151895:A:AG | acceptor_gain | 0.9900 |
| 12:113151896:C:G | acceptor_gain | 0.9900 |
AlphaMissense
1955 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:113152870:T:C | F84L | 0.931 |
| 12:113152872:T:A | F84L | 0.931 |
| 12:113152872:T:G | F84L | 0.931 |
| 12:113154444:T:C | F167L | 0.918 |
| 12:113154446:C:A | F167L | 0.918 |
| 12:113154446:C:G | F167L | 0.918 |
| 12:113154414:T:C | F157L | 0.909 |
| 12:113154416:C:A | F157L | 0.909 |
| 12:113154416:C:G | F157L | 0.909 |
| 12:113155344:T:C | F259L | 0.908 |
| 12:113155346:C:A | F259L | 0.908 |
| 12:113155346:C:G | F259L | 0.908 |
| 12:113155279:T:C | I237T | 0.906 |
| 12:113152879:T:C | F87L | 0.888 |
| 12:113152881:T:A | F87L | 0.888 |
| 12:113152881:T:G | F87L | 0.888 |
| 12:113155290:G:C | A241P | 0.882 |
| 12:113155269:T:A | W234R | 0.868 |
| 12:113155269:T:C | W234R | 0.868 |
| 12:113155293:G:C | A242P | 0.844 |
| 12:113157611:T:C | F287L | 0.838 |
| 12:113157613:C:A | F287L | 0.838 |
| 12:113157613:C:G | F287L | 0.838 |
| 12:113154612:G:C | A223P | 0.823 |
| 12:113155271:G:C | W234C | 0.814 |
| 12:113155271:G:T | W234C | 0.814 |
| 12:113155263:T:C | S232P | 0.811 |
| 12:113155279:T:G | I237S | 0.806 |
| 12:113155329:G:C | A254P | 0.803 |
| 12:113155314:G:A | G249R | 0.802 |
dbSNP variants (sampled 300 via entrez): RS1000052514 (12:113151962 G>A), RS1000421181 (12:113158056 C>G), RS1000717434 (12:113151585 G>A,C), RS1000727679 (12:113149956 G>A,T), RS1001192300 (12:113150647 C>A), RS1001223434 (12:113150917 T>C), RS1001325356 (12:113150262 A>G), RS1001456707 (12:113153748 A>C), RS1001874273 (12:113157162 C>A), RS1001981048 (12:113150312 G>T), RS1002059435 (12:113156471 G>A,C), RS1002229291 (12:113149557 T>C), RS1003184934 (12:113148022 T>A,G), RS1003215943 (12:113147888 G>A), RS1003256585 (12:113155249 G>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_2 | Body mass index | 9.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | decreases expression, increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.